Biologically Active Small Molecules

A third generation aromatase inhibitor that blocks the conversion of androgens to estrogens in peripheral tissues (IC50 = 15 nM in human placenta in vitro) without interfering with cholesterol, cortisol, or aldosterone biosynthesis used to treat

A third generation aromatase inhibitor that blocks the conversion of androgens to estrogens in peripheral tissues (IC50 = 15 nM in human placenta in vitro) without interfering with cholesterol, cortisol, or aldosterone biosynthesis used to treat

A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.

A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.

A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.

A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.

Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of

Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of

R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth

Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of

R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth

R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth